Alnylam Pharmaceuticals (ALNY) Debt Ratio (2016 - 2025)

Alnylam Pharmaceuticals has reported Debt Ratio for 8 years, with the latest figure at 0.03 in Q3 2025.

• For the quarter ending Q3 2025, Debt Ratio changed N/A year-over-year to 0.03; the trailing twelve-month figure through Sep 2025 stood at 0.03 (changed N/A YoY), and the FY2024 full-year result was 0.02, changed N/A from the prior year.
• Debt Ratio for Q3 2025 stood at 0.03, down from 0.03 in the prior quarter.
• The five-year high for Debt Ratio was 0.19 in Q4 2021, with the low at 0.02 in Q4 2024.
• Historically, Debt Ratio has averaged 0.06 across 3 years, with a median of 0.03 in 2025.
• The largest YoY upside for Debt Ratio was 230.35% in 2021 against a maximum downside of 230.35% in 2021.
• Alnylam Pharmaceuticals' Debt Ratio stood at 0.19 in 2021, then slumped by 88.07% to 0.02 in 2024, then rose by 13.01% to 0.03 in 2025.
• The last three Debt Ratio figures came in at 0.03 (Q3 2025), 0.03 (Q2 2025), and 0.03 (Q1 2025), per Business Quant data.